دورة المؤشرنت للتحليل الفني
50 دينار كويتي
Adsxd
- بادئ الموضوع مستثمر73
- تاريخ البدء
الشركة أعلنت أرباحها للربع الأول...
الأرباح ممتازه وتخلصت الشركة من جميع الديون وأصبحت في خط الربح .
الشركة مقبلة على عقود وأحتمال قبول الـ FDA لمنتج الشركة المستخدم للطب حسب ماقال رئيس الشركة أنه في مراحلة الأخير.....
هذا القبول راح يرفع السهم فوق أذا تمت الموافقة أرجو من الأخوان مراقبة هذا السهم وخصوصا خبر قبول الـ FDA للمنتج.
Applied Digital Solutions Reports First Quarter 2004 Results; First Quarter Results Yield Revenue Growth of 7.2% and Net Income of $0.03 Per Share
PALM BEACH, Fla.
CEOcast, Inc.
Ken Sgro, 212-732-4300
kensgro@ceocast.com
Applied Digital Solutions, Inc. , an advanced technology development company, today released its financial results for the first-quarter ended March 31, 2004. The Company's consolidated financial results include the financial condition, operating results and cash flows of its majority-owned subsidiaries, Digital Angel Corporation , and InfoTech USA, Inc. .
Revenue for the first quarter of 2004 was $26.9 million, a 7.2% increase from the $25.1 million in revenue in the first quarter of 2003. The increase in comparative quarterly revenue was attributable to an increase in revenue from InfoTech USA, Inc., as well as the Company's wholly-owned subsidiary Government Telecommunications, Inc.
Net Income for the first quarter of 2004 was $1.5 million, or $0.03 per share, compared to a net loss of ($26.9 million), or ($0.95) per share in the first quarter of 2003. Included in the results for the first quarter of 2003 was a non-recurring non-cash charge in the amount of $22.0 million.
"In 2003, we emphasized elimination of debt, balance sheet strengthening and building a 'foundation'. This initial phase was completed with our recent reverse stock split that right-sized our capital structure for future growth. With the first quarter results, it is clear that the accomplishments of the past year have positioned Applied Digital for success and value-building moving forward," said Scott R. Silverman, Applied Digital's Chairman and Chief Executive Officer. "In addition to our EPS of $0.03, the Company now has approximately $14 million of cash on hand and no debt at the parent level. VeriChip opportunities continue to strengthen as evidenced by the recent announcements with FN Manufacturing and the clinical studies in Italy. We believe that the FDA is in the final review of our 510k application for the medical applications of VeriChip. Since there is no 'predicate device' for VeriChip, we expect to move to a 'de novo' (new product) review process that should take no longer than 60 days." Some of the highlights of the first quarter included:
Progress in livestock-tracking opportunities. Digital Angel Corporation announced that it will begin marketing a broad range of radio-frequency identification (RFID) cattle-tracking system products in Canada under its distribution arrangement with Compass Animal Health Inc.
Growing VeriChip distribution. VeriChip Corporation has awarded the exclusive rights to distribute VeriChip in three states, including Florida, Georgia and Tennessee. The company has also awarded territories to distributors in Puerto Rico and Central America. The distributors have collectively agreed to quotas (to retain their exclusivity) to purchase 66,763 VeriChips and 4,945 scanners over the terms of the agreements. Each of the distributor's plans call for using VeriChip for security-related and emergency identification applications.
Significant government telecommunications contract work. Government Telecommunications, Inc. is on schedule to complete telecommunications network upgrades at United States Postal Service (USPS) mail processing facilities under a $15 million contract. The project is expected to be completed in May, when a total of 62 USPS sites will have been upgraded in less than 1 year.
Strengthened balance sheet. The Company ended the first quarter with $10.3 million in cash and restricted cash. Subsequent to the end of the first quarter, the Company completed a private placement with Satellite Asset Management, raising a total of $5.5 million.
وبالتوفيق أنشاء الله.
الأرباح ممتازه وتخلصت الشركة من جميع الديون وأصبحت في خط الربح .
الشركة مقبلة على عقود وأحتمال قبول الـ FDA لمنتج الشركة المستخدم للطب حسب ماقال رئيس الشركة أنه في مراحلة الأخير.....
هذا القبول راح يرفع السهم فوق أذا تمت الموافقة أرجو من الأخوان مراقبة هذا السهم وخصوصا خبر قبول الـ FDA للمنتج.
Applied Digital Solutions Reports First Quarter 2004 Results; First Quarter Results Yield Revenue Growth of 7.2% and Net Income of $0.03 Per Share
PALM BEACH, Fla.
CEOcast, Inc.
Ken Sgro, 212-732-4300
kensgro@ceocast.com
Applied Digital Solutions, Inc. , an advanced technology development company, today released its financial results for the first-quarter ended March 31, 2004. The Company's consolidated financial results include the financial condition, operating results and cash flows of its majority-owned subsidiaries, Digital Angel Corporation , and InfoTech USA, Inc. .
Revenue for the first quarter of 2004 was $26.9 million, a 7.2% increase from the $25.1 million in revenue in the first quarter of 2003. The increase in comparative quarterly revenue was attributable to an increase in revenue from InfoTech USA, Inc., as well as the Company's wholly-owned subsidiary Government Telecommunications, Inc.
Net Income for the first quarter of 2004 was $1.5 million, or $0.03 per share, compared to a net loss of ($26.9 million), or ($0.95) per share in the first quarter of 2003. Included in the results for the first quarter of 2003 was a non-recurring non-cash charge in the amount of $22.0 million.
"In 2003, we emphasized elimination of debt, balance sheet strengthening and building a 'foundation'. This initial phase was completed with our recent reverse stock split that right-sized our capital structure for future growth. With the first quarter results, it is clear that the accomplishments of the past year have positioned Applied Digital for success and value-building moving forward," said Scott R. Silverman, Applied Digital's Chairman and Chief Executive Officer. "In addition to our EPS of $0.03, the Company now has approximately $14 million of cash on hand and no debt at the parent level. VeriChip opportunities continue to strengthen as evidenced by the recent announcements with FN Manufacturing and the clinical studies in Italy. We believe that the FDA is in the final review of our 510k application for the medical applications of VeriChip. Since there is no 'predicate device' for VeriChip, we expect to move to a 'de novo' (new product) review process that should take no longer than 60 days." Some of the highlights of the first quarter included:
Progress in livestock-tracking opportunities. Digital Angel Corporation announced that it will begin marketing a broad range of radio-frequency identification (RFID) cattle-tracking system products in Canada under its distribution arrangement with Compass Animal Health Inc.
Growing VeriChip distribution. VeriChip Corporation has awarded the exclusive rights to distribute VeriChip in three states, including Florida, Georgia and Tennessee. The company has also awarded territories to distributors in Puerto Rico and Central America. The distributors have collectively agreed to quotas (to retain their exclusivity) to purchase 66,763 VeriChips and 4,945 scanners over the terms of the agreements. Each of the distributor's plans call for using VeriChip for security-related and emergency identification applications.
Significant government telecommunications contract work. Government Telecommunications, Inc. is on schedule to complete telecommunications network upgrades at United States Postal Service (USPS) mail processing facilities under a $15 million contract. The project is expected to be completed in May, when a total of 62 USPS sites will have been upgraded in less than 1 year.
Strengthened balance sheet. The Company ended the first quarter with $10.3 million in cash and restricted cash. Subsequent to the end of the first quarter, the Company completed a private placement with Satellite Asset Management, raising a total of $5.5 million.
وبالتوفيق أنشاء الله.
هذا خبر مشجع جدا
FDA
Applied Digital Updates Shareholders on the Status of the 510-K-
Application for the Medical Use of Verichip
DELRAY BEACH, Fla. & SO. ST. PAUL, Minn.
CEOcast, Inc. for Applied Digital
Ken Sgro, 212-732-4300
ksgro@ceocast.com
or
Allen & Caron Inc. for Digital Angel Corporation
Investors:
Mike Lucarelli, 212-691-8087,
m.lucarelli@allencaron.com,
or
Media:
Len Hall, 949-474-4300
len@allencaron.com
Applied Digital (NASDAQ:ADSX) As expected, the FDA has issued a letter indicating that there is no substantially equivalent device and, accordingly, a "de novo" application will immediately be filed
Applied Digital (NASDAQ:ADSX), a provider of innovative security products, announced today that Digital Angel Corporation (AMEX
OC) has received notice from the U.S. Food and Drug Administration (FDA) stating that there is no substantially equivalent device to VeriChip currently being marketed. Accordingly, the Company will immediately file a "de novo" application for VeriChip's medical uses. Statutory guidelines provide up to 60 days for the de novo review process. Digital Angel is the manufacturer of VeriChip and has licensed the technology to VeriChip Corporation, a wholly-owned subsidiary of Applied Digital, for human applications.
"We are pleased that the FDA has issued this ruling," said Scott R. Silverman, Applied Digital's Chairman and CEO. "While we certainly would have preferred this to happen sooner, we are pleased that the FDA has made this determination. This assures the Company that the FDA will determine, in a relatively short period of time, whether we can introduce the VeriChip to the health care market in the United States. As we expected this outcome, we have already prepared our de novo application and will file it immediately."
As previously disclosed, the FDA response is the long-expected result of the Companies' 510 (K) application for the medical application of VeriChip, originally filed in October 2003.
VeriChip is the world's first implantable microchip designed for human use. Digital Angel Corporation filed the 510(K) application with the FDA in October 2003 on behalf of VeriChip seeking the agency's approval to market VeriChip's healthcare information applications in the United States.
Commenting of this expected pathway, Kevin McGrath, CEO of Digital Angel Corporation stated, "We have been preparing for this day for many months. We look forward to working with the FDA to expedite its decision-making process."
Commenting on the medical application of VeriChip, Kevin Wiley, CEO of VeriChip Corporation, stated, "We continue to market and sell VeriChip internationally primarily for the security application. As evidenced by the recent chipping of Mexico's Attorney General and his staff, the VeriChip technology provides first-of-a-kind tamper-proof and secure applications. These applications can also occur with medical records and medical device information. We look forward to the de novo process and the ultimate conclusion of the regulatory process."
About the size of a grain of rice, VeriChip is a subdermal radio frequency (RFID) microchip. Once inserted under the skin in a brief outpatient procedure, the human eye cannot see VeriChip. Each VeriChip contains a unique verification number that is captured by briefly passing a proprietary scanner over the chipping site.
In addition to healthcare applications, VeriChip can be used in a variety of security, financial and emergency identification applications. The healthcare application is the only one subject to FDA clearance.
FDA
Applied Digital Updates Shareholders on the Status of the 510-K-
Application for the Medical Use of Verichip
DELRAY BEACH, Fla. & SO. ST. PAUL, Minn.
CEOcast, Inc. for Applied Digital
Ken Sgro, 212-732-4300
ksgro@ceocast.com
or
Allen & Caron Inc. for Digital Angel Corporation
Investors:
Mike Lucarelli, 212-691-8087,
m.lucarelli@allencaron.com,
or
Media:
Len Hall, 949-474-4300
len@allencaron.com
Applied Digital (NASDAQ:ADSX) As expected, the FDA has issued a letter indicating that there is no substantially equivalent device and, accordingly, a "de novo" application will immediately be filed
Applied Digital (NASDAQ:ADSX), a provider of innovative security products, announced today that Digital Angel Corporation (AMEX
OC) has received notice from the U.S. Food and Drug Administration (FDA) stating that there is no substantially equivalent device to VeriChip currently being marketed. Accordingly, the Company will immediately file a "de novo" application for VeriChip's medical uses. Statutory guidelines provide up to 60 days for the de novo review process. Digital Angel is the manufacturer of VeriChip and has licensed the technology to VeriChip Corporation, a wholly-owned subsidiary of Applied Digital, for human applications. "We are pleased that the FDA has issued this ruling," said Scott R. Silverman, Applied Digital's Chairman and CEO. "While we certainly would have preferred this to happen sooner, we are pleased that the FDA has made this determination. This assures the Company that the FDA will determine, in a relatively short period of time, whether we can introduce the VeriChip to the health care market in the United States. As we expected this outcome, we have already prepared our de novo application and will file it immediately."
As previously disclosed, the FDA response is the long-expected result of the Companies' 510 (K) application for the medical application of VeriChip, originally filed in October 2003.
VeriChip is the world's first implantable microchip designed for human use. Digital Angel Corporation filed the 510(K) application with the FDA in October 2003 on behalf of VeriChip seeking the agency's approval to market VeriChip's healthcare information applications in the United States.
Commenting of this expected pathway, Kevin McGrath, CEO of Digital Angel Corporation stated, "We have been preparing for this day for many months. We look forward to working with the FDA to expedite its decision-making process."
Commenting on the medical application of VeriChip, Kevin Wiley, CEO of VeriChip Corporation, stated, "We continue to market and sell VeriChip internationally primarily for the security application. As evidenced by the recent chipping of Mexico's Attorney General and his staff, the VeriChip technology provides first-of-a-kind tamper-proof and secure applications. These applications can also occur with medical records and medical device information. We look forward to the de novo process and the ultimate conclusion of the regulatory process."
About the size of a grain of rice, VeriChip is a subdermal radio frequency (RFID) microchip. Once inserted under the skin in a brief outpatient procedure, the human eye cannot see VeriChip. Each VeriChip contains a unique verification number that is captured by briefly passing a proprietary scanner over the chipping site.
In addition to healthcare applications, VeriChip can be used in a variety of security, financial and emergency identification applications. The healthcare application is the only one subject to FDA clearance.
undercover
عضو نشط
- التسجيل
- 23 يوليو 2003
- المشاركات
- 484
أتوقع ينفجر اليوم ويرتفع 5 سنت :d
السهم ذا ميت ماحركته ولا أخبار العقود
(
السهم ذا ميت ماحركته ولا أخبار العقود
(
دورة المؤشرنت للتحليل الفني
50 دينار كويتي